av/g1-therapeutics--big.svg

COM:G1THERAPEUTICS

G1 Therapeutics, Inc.

  • Stock

Last Close

3.95

26/07 20:00

Market Cap

145.87M

Beta: -

Volume Today

492.24K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.27
-
0.02
91.99%
0.20
-
0.12
37.48%
0.27
120.32%
0.68
148.74%
cash conversion cycle
-21.48
-
169.88
-
930.86
447.94%
484.79
47.92%
cash per share
3.01
-
1.12
62.70%
2.32
106.23%
5.70
146.36%
11.08
94.30%
7.18
35.23%
5.47
23.76%
5.27
3.65%
3.33
36.94%
1.59
52.21%
company equity multiplier
1.10
-
1.10
0.03%
1.13
2.94%
1.13
0.52%
-1.73
253.76%
-0.85
51.17%
-0.52
38.02%
-0.43
17.04%
2.73
728.90%
3.43
25.62%
days of inventory outstanding
628.43
-
1.58K
150.72%
631.18
59.94%
days of payables outstanding
21.48
-
524.51
-
723.67
37.97%
202.51
72.02%
days of sales outstanding
1.91
-
65.96
3,352.92%
78.93
19.67%
56.12
28.90%
dividend yield
ebit per revenue
-6.40
-
-29.55
361.36%
-2.13
-
-4.53
112.44%
-2.65
41.35%
-0.48
81.95%
ebt per ebit
1.00
-
1.31
31.37%
1.00
24.13%
0.99
1.06%
0.96
3.13%
0.95
0.66%
1.01
6.88%
1.03
2.04%
1.07
3.50%
1.13
5.94%
effective tax rate
-0.08
-
-0.24
218.64%
-0.00
98.87%
-0.00
74.88%
-0.05
6,773.80%
0.00
106.20%
-0.01
595.66%
-0.01
56.46%
-0.01
85.76%
-0.07
495.88%
enterprise value multiple
-2.21
-
-26.94
1,119.29%
-8.57
68.19%
-4.23
50.66%
-3.01
28.82%
-5.67
88.51%
-5.22
7.92%
-2.03
61.10%
-1.68
17.54%
-4.68
179.41%
fixed asset turnover
10.08
-
3.55
64.74%
4.31
-
3.48
19.28%
6.45
85.47%
12.92
100.32%
free cash flow per share
-5.38
-
-0.68
87.32%
-1.24
82.25%
-2.79
124.67%
-2.25
19.36%
-2.73
21.15%
-2.21
18.95%
-3.15
42.47%
-2.96
6.03%
-0.74
74.96%
gross profit margin
-3.81
-
1
126.22%
1
-
0.94
6.40%
0.93
0.96%
0.91
1.53%
interest coverage
-54.26
-
-30.52
43.75%
-13.05
57.23%
-3.94
69.83%
inventory turnover
0.58
-
0.23
60.11%
0.58
149.63%
long term debt to capitalization
-0.03
-
-0.07
133.35%
-0.16
139.88%
0.55
434.76%
0.59
8.64%
net income per ebt
1.08
-
1
7.00%
1
0%
1
0%
1
0%
1.00
0.29%
1.01
1.74%
1.01
0.80%
1.01
0.53%
1.07
5.71%
net profit margin
-6.89
-
-38.82
463.69%
-2.19
-
-4.71
115.04%
-2.88
38.97%
-0.58
79.79%
operating cash flow per share
-5.29
-
-0.68
87.20%
-1.23
81.59%
-2.78
125.58%
-2.23
19.66%
-2.66
19.05%
-2.21
16.74%
-3.15
42.47%
-2.95
6.40%
-0.74
74.86%
operating cycle
694.39
-
1.65K
138.27%
687.30
58.46%
operating profit margin
-6.40
-
-29.55
361.36%
-2.13
-
-4.53
112.44%
-2.65
41.35%
-0.48
81.95%
payables turnover
17.00
-
0.70
-
0.50
27.52%
1.80
257.35%
pretax profit margin
-6.40
-
-38.82
506.09%
-2.16
-
-4.68
116.78%
-2.84
39.30%
-0.54
80.88%
price fair value
5.30
-
14.10
166.16%
7.20
48.98%
3.87
46.27%
-2.98
176.97%
-2.94
1.13%
-1.56
46.89%
-0.73
53.11%
3.45
570.28%
4.46
29.40%
receivables turnover
191.08
-
5.53
97.10%
4.62
16.44%
6.50
40.64%
return on assets
-1.88
-
-0.85
54.87%
-0.63
25.90%
-0.57
9.01%
-0.23
59.81%
-0.43
86.59%
-0.43
1.31%
-0.58
34.44%
-0.79
34.46%
-0.39
49.73%
return on capital employed
-1.92
-
-0.71
63.07%
-0.71
0.54%
-0.65
8.59%
-0.25
61.86%
-0.49
95.70%
-0.47
3.38%
-0.63
33.73%
-0.89
42.08%
-0.43
51.83%
return on equity
-2.07
-
-0.93
54.88%
-0.71
23.73%
-0.64
9.49%
0.40
161.79%
0.36
8.88%
0.23
37.21%
0.25
11.53%
-2.15
945.61%
-1.36
36.85%
total debt to capitalization
-0.03
-
-0.11
260.96%
-0.17
46.71%
0.55
431.57%
0.60
9.04%

All numbers in (except ratios and percentages)